Atlas Trials

Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma

Clinical trial NCT00816543 · COMPLETED

Trial details

NCT number
NCT00816543
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2008-12-01
Primary completion
2012-05-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.